·         APLAR validation of Behcet’s disease (BD) diagnosis criteria, Iran experience, F. Davatchi, F. Shahram, M. Akbarian, F. Gharibdoost, A. Nadji, C. Chams, H. Chams

·         Audiovestibular involvement in Behcet’s Disease (in patients with disease duration of more than 5 years), F. Shahram, F. Sabeti, F. Davatchi, M. Khalessi, M. Akbarian, N. Shariati

·         Behcet’s disease and pregnancy, A. Nadji, F. Shahram, F. Davatchi, M. Akbarian, F. Gharibdoost, A. Jamshidi

·         Behcet’s disease treatment, C. Chams-Davatchi, F. Davatchi, F. Shahram

·         Clinical Features of Behcet’s Disease in Children: A Collaborative Study of 86 cases, I. Kone’-Paut, S. Yurdakul, S. Bahabri, N. Shafae, S. Ozen, H. Ozdogan, JL. Bernard

·         Cyclosporine in severe Ocular Lesions of Behcet’s Disease, F. Shahram, F. Davatchi, H. Chams, M. Akbarian

·         Cyclosporine in the treatment of severe ocular lesions of Behcet’s disease, F. Gharibdoost, F. Shahram, F. Davatchi, H. Chams, M. Akbarian, A. Nadji

·         Effects of Suppressive Therapy with Levothyroxine on Bone Density, B. Larijanie, F. Gharibdoost, M. Pajoohi, M. Bastanhagh, A. Sajadi, M. Shirzad, F. Davatchi

·         IN TIME VARIATION OF PATHERGY PHENOMENON IN BEHCET'S DISEASE, C. Chams., F. Davatchi., F. Shahram., M. Akbarian., F. Gharibdoost., A. Nadji. and A.R. Jamshidi

·         Iran’s Aspect of Behcet’s Disease in Children, the 1996 Survey, N. Shafaie, F. Shahram, A. Nadji, F. Davatchi, M. Akbarian, F. Gharibdoost, A. Jamshidi

·         Longitudinal study of the Pathergy phenomenon in Behcet’s Disease (BD), C. Chams, F. Davatchi, F. Shahram, M. Akbarian, F. Gharibdoost, A. Nadji

·         Outcome analysis of ocular lesions in Behcet’s disease with six different therapeutic methods, F. Davatchi, F. Shahram, F. Gharibdoost, M. Akbarian, A. Nadji, H. Chams, C. Chams

·         Outcome measurement of ocular lesions in Behcet’s disease, F. Davatchi, S. Soroosh, F. Shahram, H. Chams, M. Akbarian, F. Gharibdoost, A. Nadji, C. Shams

·         Overview Of Pathogenesis & Management Of Behcet’s Disease, F. Davatchi

·         Prolactin Level in Behcet’s Disease, F. Shahram, F. Malek, F. Davatchi, M. Akbarian, F. Gharibdoost, A. Nadji

·         Proposed ocular Behcet therapeutic scoring & activity/chronicity ratio. H. Chams, F. Shahram, F. Davatchi, M. Akbarian, F. Gharibdoost, A. Nadji, S. Chams.

·         Proposed ocular Behcet therapeutic scoring and activity/chronicity ratio, H. Chams, F. Shahram, F. Davatchi, M. Akbarian, F. Gharibdoost, A. Nadji. S. Chams

·         THE 1996 SURVEY OF BEHCET'S DISEASE IN IRAN, STUDY OF 3153 CASES, F. Shahram, F. Davatchi, M. Akbarian, F. Gharibdoost, A. Nadji, A. Jamshidi, H. Chams

·         The Accuracy of IBDDAM in the Treatment Evaluation of Behcet’s Disease, A. Jamshidi, F. Shahram, F. Davatchi, M. Akbarian, F. Gharibdoost, A. Nadji

·         Treatment of Ocular Lesions in Behcet’s Disease  (Outcome Analysis of Six Different Therapeutic Methods). Farhad Shahram MD.

·         Treatment of Ophthalmologic Manifestations Of Behcet’s Disease Comparison Of 6 Methods, F. Davatchi, F. Shahram, H. Chams, M. Akbarian, F. Gharibdoost, A. Nadji, C. Chams.